Klatzmann D, Gluckman J C, Foucault C, Bensussan A, Assobga U, Duboust A
Transplantation. 1983 Apr;35(4):332-8. doi: 10.1097/00007890-198304000-00014.
To investigate the mechanism of the beneficial effect of blood transfusions (BT) on subsequent kidney transplant survival, we have studied the influence of planned BT on lymphocyte reactivity in previously nontransfused uremic patients. A marked decrease in mixed-lymphocyte reactions (MLR) to the donor and to other unrelated cells was observed soon after the first BT in 38% of the patients. This effect waned thereafter, but additional transfusions led to more pronounced and prolonged reductions. A sustained and nonspecific reduction that appeared only after the second or third BT was observed in 24% of the patients. Other patients had only a transient decrease, but otherwise MLR were normal or even increased. Modifications of the response to mitogens or to soluble antigens were also noted but, except for PPD, they were not related to BT. Most of the lymphocyte suspensions in which proliferation was reduced after BT could inhibit the response of autologous cells taken before BT, when they were mixed together in three-cell experiments. Since these suspensions were usually not cytotoxic to the stimulating cells in direct 51Cr release assays, inhibition could be attributed to suppressor cells. These results indicate that nonspecific suppression to allogeneic cells can be generated in vivo by BT.
为了研究输血(BT)对后续肾移植存活有益作用的机制,我们研究了计划性输血对既往未输血的尿毒症患者淋巴细胞反应性的影响。在38%的患者首次输血后不久,观察到对供体及其他无关细胞的混合淋巴细胞反应(MLR)显著降低。此后这种效应逐渐减弱,但再次输血会导致更明显且持续时间更长的反应降低。在24%的患者中观察到仅在第二次或第三次输血后出现持续且非特异性的反应降低。其他患者仅有短暂降低,除此之外MLR正常甚至升高。对有丝分裂原或可溶性抗原反应的改变也有记录,但除了结核菌素纯蛋白衍生物(PPD)外,这些改变与输血无关。在三细胞实验中,当将输血后增殖降低的大多数淋巴细胞悬液与输血前采集的自体细胞混合时,它们能够抑制自体细胞的反应。由于这些悬液在直接51Cr释放试验中通常对刺激细胞无细胞毒性,因此抑制作用可归因于抑制细胞。这些结果表明输血可在体内产生对同种异体细胞的非特异性抑制。